Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cureus ; 14(7): e26922, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35983380

RESUMO

Salmonella infection is a major public health concern worldwide. While non-typhoidal Salmonella serovars typically present with gastroenteritis, a disseminated infection may occur in high-risk individuals. After the initial invasion of the gastrointestinal mucosa, Salmonella spp. are capable of hematogenous dissemination throughout the body, leading to significant morbidity and mortality. We present a case of an immunocompromised patient with lower extremity abscesses, septic arthritis, and necrotizing fasciitis to highlight an uncommon presentation of disseminated Salmonella infection.

2.
Liver Res ; 1(2): 81-87, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29276644

RESUMO

The liver possesses an extraordinary ability to regenerate after injury. Hepatocyte-driven liver regeneration is the default pathway in response to mild-to-moderate acute liver damage. When replication of mature hepatocytes is blocked, facultative hepatic progenitor cells (HPCs), also referred to as oval cells (OCs) in rodents, are activated. HPC/OCs have the ability to proliferate clonogenically and differentiate into several lineages including hepatocytes and bile ductal epithelia. This is a conserved liver injury response that has been studied in many species ranging from mammals (rat, mouse, and human) to fish. In addition, improper HPC/OC activation is closely associated with fibrotic responses, characterized by myofibroblast activation and extracellular matrix production, in many chronic liver diseases. Matrix remodeling and metalloprotease activities play an important role in the regulation of HPC/OC proliferation and fibrosis progression. Thus, understanding molecular mechanisms underlying HPC/OC activation has therapeutic implications for rational design of anti-fibrotic therapies.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA